EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Urea cycle fumarate limits fibrosis post-myocardial infarction by reducing fibroblast mitochondrial adenosine triphosphate production

Jing Zhao, Yating Ruan, Yongjian Chen, Qiming Chen, Tingting Hong, Linjun Wang, Yinghui Xu, Liya Hou, Fei Liao, Deling Yin, Cheng Ni iD

Cardiovascular Research · 2026

DOI: 10.1093/cvr/cvag119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2026. Verfasst von Jing Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology of the Second Affiliated Hospital, School of Medicine, Zhejiang University, 88# Jiefang Road, Hangzhou, Zhejiang Province 31…. Hauptthemen laut MEDLINE: Adenosine Triphosphate, Fumarates, Myocardial Infarction, Urea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cardiac fibrosis, a common pathological outcome of various heart diseases including myocardial infarction (MI), is primarily driven by the activation and trans-differentiation of cardiac fibroblasts that demand substantial adenosine triphosphate production (ATP) for energy. Although sodium-glucose co-transporter 2 (SGLT2) inhibitors such as dapagliflozin have been shown to improve outcomes in heart failure, their direct impact on cardiac fibrosis, particularly through the modulation of fibroblast energy metabolism remains unexplored. Methods and results We employed an integrated strategy combining metabolomics and metabolic flux analysis to investigate metabolic reprogramming in cardiac fibroblasts under ischaemic conditions. Our findings confirmed that treatment with an SGLT2 inhibitor confers anti-fibrotic benefits post-MI. Multi-omics analysis identified a key metabolic pathway modulated in fibroblasts from SGLT2 inhibitor-treated mice under ischaemia: the conversion of N-acetyl-glutamate (NAcGlu) to fumarate, catalysed by argininosuccinate lyase (ASL). This pathway serves as a metabolic bridge linking the urea cycle to the tricarboxylic acid (TCA) cycle. Exogenous supplementation with either NAcGlu or fumarate significantly improved cardiac function and reduced fibrosis after MI. In contrast, targeted deletion of ASL in activated cardiac fibroblasts impaired cardiac performance, even with NAcGlu supplementation. Mechanistically, we found that fumarate accumulation under stress presses the TCA cycle in cardiac fibroblasts, resulting in reduced ATP production.

Conclusion

These findings identify the NAcGlu/ASL/fumarate axis as an important regulator of fibroblast metabolism and trans-differentiation during ischaemic stress. Our data are consistent with a model in which targeting key metabolites (NAcGlu, fumarate) or enzymes (ASL) in the urea cycle pathway of cardiac fibroblasts may point to a potential therapeutic strategy to combat adverse cardiac fibrosis following MI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenosine TriphosphateFumaratesMyocardial InfarctionUreaEnergy MetabolismFibroblastsMitochondria, HeartMyocardiumAnimalsFibrosisDisease Models, AnimalMice, Inbred C57BLCells, CulturedMetabolic ReprogrammingMale

Stichwörter der Autor:innen

Arginine biosynthesisCardiac fibrosisFumarateMyocardial infarctionUrea cycle

Substanzen

Adenosine TriphosphateFumaratesUrea

Autor:innen und Institutionen

  • Department of Cardiology of the Second Affiliated Hospital, School of Medicine, Zhejiang University, 88# Jiefang Road, Hangzhou, Zhejiang Province 310009, China.
  • State Key Laboratory of Transvascular Implantation Devices, 88# Jiefang Road, Hangzhou, Zhejiang Province 310009, China.
  • Heart Regeneration and Repair Key Laboratory of Zhejiang Province, 88# Jiefang Road, Hangzhou, Zhejiang Province 310009, China.
  • Transvascular Implantation Devices Research Institute, Binjiang Institute of Zhejiang University, Building 2, Huoju Innovation Center, No. 239 Jucai Road, Changhe Subdistrict, Binjiang District, Hangzhou, Zhejiang Provi…
  • Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.

ORCID-Profile: Cheng Ni

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhao, J., Ruan, Y., Chen, Y., Chen, Q., Hong, T., Wang, L., Xu, Y., Hou, L., Liao, F., Yin, D., & Ni, C. (2026). Urea cycle fumarate limits fibrosis post-myocardial infarction by reducing fibroblast mitochondrial adenosine triphosphate production. Cardiovascular Research. https://doi.org/10.1093/cvr/cvag119

Vancouver

Zhao J, Ruan Y, Chen Y, Chen Q, Hong T, Wang L, et al. Urea cycle fumarate limits fibrosis post-myocardial infarction by reducing fibroblast mitochondrial adenosine triphosphate production. Cardiovascular Research. 2026. doi:10.1093/cvr/cvag119

BibTeX
@article{Zhao2026,
  author = {Zhao, Jing and Ruan, Yating and Chen, Yongjian and Chen, Qiming and Hong, Tingting and Wang, Linjun and Xu, Yinghui and Hou, Liya and Liao, Fei and Yin, Deling and Ni, Cheng},
  title = {Urea cycle fumarate limits fibrosis post-myocardial infarction by reducing fibroblast mitochondrial adenosine triphosphate production},
  journal = {Cardiovascular Research},
  year = {2026},
  doi = {10.1093/cvr/cvag119}
}
Kostenlos starten →